Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
5
×
Tags
national blog main
5
×
biotech
life sciences
national top stories
boston
boston blog main
boston top stories
national
san diego blog main
wisconsin
wisconsin blog main
wisconsin top stories
accelerators
astellas pharma
atlas venture
audentes therapeutics
avidity biosciences
bluebird bio
cancer
centers for medicare and medicaid services
clinical trials
cms
cologuard
colon cancer
colorectal cancer
deals
dna
duchenne muscular dystrophy
dyne therapeutics
event
exabyte
exact sciences
facioscapulohumeral muscular dystrophy
fda
food and drug administration
gene therapy
healthcare
joshua brumm
kaleido biosciences
life science
What
early
5
×
sciences
bird
breakthroughs
life
xcelerating
accelerating
adversity
ago
attend
based
beats
biomedical
biopharma's
biopharma’s
biotechs
boston
business
case
cash
cold
conference
considering
data
dealing
diego’s
digital
discussed
diseases
drug
dyne
ending
ends
exact
expected
experimental
eyes
facilities
flu
forecasts
Language
unset
Current search:
early
×
photo
×
" national blog main "
×
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
4 years ago
Early Bird Sale Ends Today for Xcelerating Life Sciences Boston: Biopharma’s Future in Digital Health
@xconomy.com
4 years ago
Early Bird Sale Ending for San Diego’s Xcelerating Life Sciences Conference
@xconomy.com
5 years ago
With New Cash and Facilities, Phoenix Transitions Out Of Startup Mode
@xconomy.com
6 years ago
Exact Sciences Beats Quarterly Forecasts, Sending Its Stock Price Up